Leukapheresis is a laboratory procedure to separate white blood cells from a sample of blood which can occur with chronic lymphocytic leukemia (CLL). Leukapheresis is a good treatment option for ...
Preapheresis quantification of circulating CD34+ cells (CD34) may be used to predict peripheral blood progenitor cell (PBPC) yield in subsequent leukapheresis products. In this study, we ...
Sergey Shevkoplyas, a professor of biomedical engineering at University of Houston, is leading a team developing new devices for treating children with hyperleukocytosis, a condition that develops ...
CHICAGO, April 6, 2021 /PRNewswire/ -- According to the new market research report "Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), ...
Acute Myeloid Leukaemia (AML) is an aggressive haematological malignancy, notable for its rapid progression and complex treatment requirements. A critical complication in AML is hyperleukocytosis, a ...
Abstract and Introduction Patients, Materials and Methods Results Discussion References Because of its reliability, rapidity, and simplicity in performance, flow cytometry CD34 analysis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results